The clinical impact of different assays for prostate specific antigen
- 1 September 2000
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 86 (5) , 590-597
- https://doi.org/10.1046/j.1464-410x.2000.00858.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Molecular cloning of human prostate specific antigen cDNAPublished by Wiley ,2001
- Primary Care Practitioners: An Analysis of their Perceptions of Voiding Dysfunction and Prostate CancerJournal of Urology, 1996
- The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA densityUrology, 1995
- Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinomaBritish Journal of Urology, 1995
- Methodological and clinical comparison of the acs prostate-specific antigen assay and the tandem-e prostate-specific antigen assay in prostate cancerUrology, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Analysis of variation in prostate-specific antigen valuesUrology, 1993
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990
- Prostate‐specific antigen and prostate gland volume: Correlation and clinical applicationJournal of Clinical Laboratory Analysis, 1990